Ethane

Ethane

SCHEMBL1067664

CC.CS(=O)(=O)O.CS(=O)(=O)O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of Ethane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.54
KDM4E B2RXH2 3/20 0.50
CA5A P35218 2/20 0.50
CA5B Q9Y2D0 2/20 0.50
CYP3A4 P08684 2/20 0.50
TSHR P16473 4/20 0.42
CA1 P00915 4/20 0.42
CA9 Q16790 2/20 0.42
NT5E P21589 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA7 P43166 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
USP2 O75604 1/20 0.36
CA12 O43570 1/20 0.33
BLM P54132 2/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethane SCHEMBL273722 1.00
SCHEMBL8596055 0.94 CA2 (0.58) CA2KDM4ECA5ACA5BCYP3A4
SCHEMBL246838 0.94 CA2 (0.58) CA2KDM4ECA5ACA5BCYP3A4
SCHEMBL105 0.94
SCHEMBL15109974 0.94
SCHEMBL128169 0.94
SCHEMBL25599 0.94 CA2 (0.58) CA2KDM4ECA5ACA5BCYP3A4
SCHEMBL579101 0.89
SCHEMBL20570964 0.89
SCHEMBL8729088 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117778297-A Method for establishing nile tilapia testis interstitial cell line 西部(重庆)科学城种质创制大科学中心 2024-03-29 CN disclosed
CN-117045678-A Application of human umbilical cord mesenchymal stem cells and exosomes thereof in preparing medicament for treating physiological testis aging and related diseases 中山大学附属第一医院 2023-11-14 CN disclosed
CN-116999537-A Application of fibroblast growth factor 9 in treating testicular hypofunction 温州医科大学附属第二医院(温州医科大学附属育英儿童医院) 2023-11-07 CN disclosed
CN-112111548-A Method for testing that SLC can maintain Leydig and myoid cell homeostasis in adult testis 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 2020-12-22 CN disclosed
CN-105255826-B Method of inducing differentiation and application thereof of the people iPS cell to interstitial glands 中山大学 2019-01-08 CN disclosed
US-20180371408-A1 CELL CULTURES AND METHODS OF USE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 2018-12-27 US disclosed
US-9937227-B2 Humanin, analogs and cancer treatment methods and uses thereof LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) 2018-04-10 US disclosed
CN-104212763-B A kind of separation of interstitial tissue[of testis] stem cell, cultural method and application thereof 中山大学 2017-09-15 CN disclosed
CN-104212767-B A kind of separation for the interstitial tissue[of testis] stem cell for expressing nestin, cultural method and application thereof 中山大学 2017-09-01 CN disclosed
US-20160082080-A1 HUMANIN, ANALOGS AND CANCER TREATMENT METHODS AND USES THEREOF LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER 2016-03-24 US disclosed
WO-2003072749-A2 ENKURIN AND USES THEREOF UNIVERSITY OF MASSACHUSETS (US) 2003-09-04 WO disclosed
US-6531305-B1 Isolated nucleic acid encoding a polypeptide; use in diagnosis and therapy of fertility disorders UNIVERSITY OF MASSACHUSETTS 2003-03-11 US disclosed
US-20020052011-A1 Method for evaluating and affecting male fertility UNITED STATES ENVIRONMENTAL PROTECTION AGENCY 2002-05-02 US disclosed
US-6197940-B1 POLYPEPTIDE FOR THE DETECTION OF DECREASES IN MALE REPRODUCTIVE CAPABILITIES U.S. ENVIRONMENTAL PROTECTION AGENCY 2001-03-06 US disclosed
EP-1071712-A1 SP22, A FERTILITY-ASSOCIATED PROTEIN FROM SPERM AND A METHOD FOR EVALUATING AND AFFECTING MALE FERTILITY USING IT United States Environmental Protection Agency (US) 2001-01-31 EP disclosed
WO-1999054354-A9 SP22, A FERTILITY-ASSOCIATED PROTEIN FROM SPERM AND A METHOD FOR EVALUATING AND AFFECTING MALE FERTILITY USING IT US ENVIRONMENT (US) 1999-12-16 WO disclosed
WO-1999054354-A1 SP22, A FERTILITY-ASSOCIATED PROTEIN FROM SPERM AND A METHOD FOR EVALUATING AND AFFECTING MALE FERTILITY USING IT U.S. ENVIRONMENTAL PROTECTION AGENCY (US) 1999-10-28 WO disclosed
EP-0877757-A1 METHOD FOR EVALUATING AND AFFECTING MALE FERTILITY U.S. Environmental Protection Agency (US) 1998-11-18 EP disclosed
US-5763402-A Promotion or inhibition of spermatogenesis THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 1998-06-09 US disclosed
WO-1997027218-A1 METHOD FOR EVALUATING AND AFFECTING MALE FERTILITY U.S. ENVIRONMENTAL PROTECTION AGENCY (US) 1997-07-31 WO disclosed